BMJ updates

Second generation antidepressants should remain an option for children and adolescents with depression or anxiety

BMJ 2007; 335 doi: 10.1136/bmj.39213.559317.DE (Published 20 September 2007)
Cite this as: BMJ 2007;335:607

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Abstract

Research question Are second generation antidepressants associated with suicidal ideation or suicide attempts in children and adolescents with depression or anxiety?

Answer Yes, but the risk is small and statistically non-significant. In general, the benefits of these agents outweigh the risks.

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL